{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:56Z","timestamp":1792664156199,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021914","name":"Grand Challenges","doi-asserted-by":"publisher","award":["INV-004923"],"award-info":[{"award-number":["INV-004923"]}],"id":[{"id":"10.13039\/100021914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","award":["HKU3-8"],"award-info":[{"award-number":["HKU3-8"]}],"id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","award":["BM48-31"],"award-info":[{"award-number":["BM48-31"]}],"id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005302","name":"University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["17-ID-2"],"award-info":[{"award-number":["17-ID-2"]}],"id":[{"id":"10.13039\/100005302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006231","name":"Brookhaven National Laboratory","doi-asserted-by":"publisher","award":["DE-SC0012704"],"award-info":[{"award-number":["DE-SC0012704"]}],"id":[{"id":"10.13039\/100006231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012422","name":"Children&apos;s Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI082724"],"award-info":[{"award-number":["U19AI082724"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019R00028"],"award-info":[{"award-number":["75N93019R00028"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI057266"],"award-info":[{"award-number":["U19AI057266"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI190286"],"award-info":[{"award-number":["R01AI190286"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI109946"],"award-info":[{"award-number":["U19AI109946"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.celrep.2026.117137","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:55:04Z","timestamp":1774122904000},"page":"117137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity"],"prefix":"10.1016","volume":"45","author":[{"given":"Yanbin","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Halfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan C.","family":"Chervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe A.","family":"Troxell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriruk","family":"Changrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-1245","authenticated-orcid":false,"given":"Patrick C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117137_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2026.117137_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2026.117137_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2026.117137_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.celrep.2026.117137_bib5","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/infdis\/jiad181","article-title":"The burden of COVID-19 in the immunocompromised patient: Implications for vaccination and needs for the future","volume":"228","author":"Antinori","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117137_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the omicron variant from previous SARS-CoV-2 infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117137_bib7","article-title":"Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants","volume":"16","author":"Li","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2026.117137_bib8","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117137_bib9","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","article-title":"Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion","volume":"15","author":"Planas","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117137_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/jcm9041225","article-title":"The COVID-19 pandemic: A comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control","volume":"9","author":"Helmy","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.celrep.2026.117137_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.abc7424","article-title":"Broad neutralization of SARS-related viruses by human monoclonal antibodies","volume":"369","author":"Wec","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","article-title":"Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117137_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.abf4830","article-title":"Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody","volume":"371","author":"Rappazzo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03817-4","article-title":"Broad sarbecovirus neutralization by a human monoclonal antibody","volume":"597","author":"Tortorici","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj7125","article-title":"A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice","volume":"14","author":"Martinez","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117137_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109760","article-title":"Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies","volume":"36","author":"Jette","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117137_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2026.117137_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib21","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2026.117137_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009089","article-title":"A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody","volume":"16","author":"Wu","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2026.117137_bib24","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/s41467-020-19146-5","article-title":"Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein","volume":"11","author":"Wrobel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117137_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.chom.2020.06.010","article-title":"Neutralization of SARS-CoV-2 by destruction of the prefusion spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2026.117137_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2026.117137_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abk3516","article-title":"Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution","volume":"16","author":"Zhao","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2026.117137_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/07391102.2021.2004230","article-title":"Affinity enhancement of CR3022 binding to RBD; in silico site directed mutagenesis using molecular dynamics simulation approaches","volume":"41","author":"Shariatifar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.celrep.2026.117137_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2174\/1386207323666201026160500","article-title":"Mechanistic insights to the binding of antibody CR3022 against RBD from SARS-CoV and HCoV-19\/SARS-CoV-2: A computational study","volume":"24","author":"Yu","year":"2021","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.celrep.2026.117137_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/v14020186","article-title":"Structure based affinity maturation and characterizing of SARS-CoV antibody CR3022 against SARS-CoV-2 by computational and experimental approaches","volume":"14","author":"Yu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2026.117137_bib31","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1080\/07391102.2022.2030800","article-title":"Exploring the role of framework mutations in enabling breadth of a cross-reactive antibody (CR3022) against the SARS-CoV-2 RBD and its variants of concern","volume":"41","author":"Saini","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.celrep.2026.117137_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1922134","article-title":"Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies","volume":"13","author":"Rouet","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2026.117137_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2020.10.012","article-title":"Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies","volume":"538","author":"Yuan","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2026.117137_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143129","article-title":"Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022","volume":"6","author":"Atyeo","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2026.117137_bib35","doi-asserted-by":"crossref","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117137_bib36","article-title":"Optimized immunoglobulin knock-ins using Cas9 reveal peritoneal B cell lineage relationships in vivo","author":"Erickson","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2026.117137_bib37","doi-asserted-by":"crossref","first-page":"W262","DOI":"10.1093\/nar\/gkq391","article-title":"RSSsite: a reference database and prediction tool for the identification of cryptic recombination signal sequences in human and murine genomes","volume":"38","author":"Merelli","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117137_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190982","article-title":"Characterization of the naive murine antibody repertoire using unamplified high-throughput sequencing","volume":"13","author":"Rettig","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117137_bib39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.cell.2015.06.003","article-title":"Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice","volume":"161","author":"Dosenovic","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117137_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.immunol.23.021704.115728","article-title":"Marginal zone B cells","volume":"23","author":"Pillai","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117137_bib41","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.173.5.1213","article-title":"Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow","volume":"173","author":"Hardy","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117137_bib42","article-title":"Flow cytometric characterization of murine B cell development","volume":"167","author":"Harris","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.celrep.2026.117137_bib43","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/nprot.2016.102","article-title":"Sequencing and cloning of antigen-specific antibodies from mouse memory B cells","volume":"11","author":"von Boehmer","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2026.117137_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41586-022-05371-z","article-title":"Functional antibodies exhibit light chain coherence","volume":"611","author":"Jaffe","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","article-title":"CoV-AbDab: the coronavirus antibody database","volume":"37","author":"Raybould","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117137_bib46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib47","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1038\/s41467-023-38965-w","article-title":"A rapid cell-free expression and screening platform for antibody discovery","volume":"14","author":"Hunt","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117137_bib48","article-title":"Breadth and function of antibody response to acute SARS-CoV-2 infection in humans","volume":"17","author":"Huang","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2026.117137_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2026.117137_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib51","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117137_bib52","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/eji.201747019","article-title":"A new staining protocol for detection of murine antibody-secreting plasma cell subsets by flow cytometry","volume":"47","author":"Pracht","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2026.117137_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add5960","article-title":"Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates","volume":"16","author":"Prabhakaran","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117137_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41590-020-0660-2","article-title":"Novel specialized cell state and spatial compartments within the germinal center","volume":"21","author":"Kennedy","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117137_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.it.2022.01.003","article-title":"Unraveling B cell trajectories at single cell resolution","volume":"43","author":"Morgan","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2026.117137_bib56","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41590-020-0713-6","article-title":"The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development","volume":"21","author":"Laidlaw","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117137_bib57","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41423-020-0458-z","article-title":"Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies","volume":"17","author":"Yi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2026.117137_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104916","article-title":"Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2\/5 subvariants in the upper and lower respiratory tract","volume":"99","author":"Hu","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2026.117137_bib60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104232","article-title":"Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract","volume":"83","author":"Hui","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2026.117137_bib62","doi-asserted-by":"crossref","first-page":"D256","DOI":"10.1093\/nar\/gki010","article-title":"IMGT\/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes","volume":"33","author":"Giudicelli","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117137_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115948","article-title":"Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift","volume":"44","author":"Song","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117137_bib64","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241563","article-title":"In vivo antibody diversification targeting a conserved coronavirus epitope","volume":"222","author":"Nair","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117137_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111845","article-title":"Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents","volume":"41","author":"Cao","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117137_bib66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-022-05644-7","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117137_bib67","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/j.1460-2075.1988.tb03038.x","article-title":"Antibody engineering for the analysis of affinity maturation of an anti-hapten response","volume":"7","author":"Allen","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2026.117137_bib68","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.chom.2020.07.001","article-title":"Antibody feedback limits the expansion of B cell responses to malaria vaccination but drives diversification of the humoral response","volume":"28","author":"McNamara","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2026.117137_bib69","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.immuni.2024.06.009","article-title":"Antibody modulation of B cell responses-incorporating positive and negative feedback","volume":"57","author":"Cyster","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117137_bib70","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2020.09.007","article-title":"HIV-1 VRC01 germline-targeting immunogens select distinct epitope-specific B cell receptors","volume":"53","author":"Lin","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117137_bib71","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nbt.2825","article-title":"Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery","volume":"32","author":"Lee","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117137_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4682-11-30","article-title":"Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT\/LIGM-DB with IMGT\/HighV-QUEST","volume":"11","author":"Shi","year":"2014","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.celrep.2026.117137_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.celrep.2026.117137_bib74","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117137_bib75","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117137_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117137_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02975-21","article-title":"Cross-neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike","volume":"12","author":"Changrob","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2026.117137_bib78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-8958-4_5","article-title":"An efficient method to generate monoclonal antibodies from human B cells","volume":"1904","author":"Guthmiller","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117137_bib79","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117137_bib80","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726002159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726002159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:32:43Z","timestamp":1786221163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726002159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2211124726002159"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117137","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117137"}}